Streptococcal lung abscesses from a dental focus following tocilizumab: a case report

MD de Kruif; Eric van Gorp; EH Bel; DM Gerlag; PW Kunst

Streptococcal lung abscesses from a dental focus following tocilizumab: a case report

MD de Kruif
, Eric van Gorp
, EH Bel
, DM Gerlag
, PW Kunst

Virology

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

Abstract

Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.

Original language	Undefined/Unknown
Pages (from-to)	951-953
Number of pages	3
Journal	Clinical & Experimental Rheumatology
Volume	30
Issue number	6
Publication status	Published - 2012

Research programs

EMC MM-04-27-01

Cite this

@article{2c82ae378a6d451c94d4b427b3034e4c,

title = "Streptococcal lung abscesses from a dental focus following tocilizumab: a case report",

abstract = "Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.",

author = "\{de Kruif\}, MD and \{van Gorp\}, Eric and EH Bel and DM Gerlag and PW Kunst",

year = "2012",

language = "Undefined/Unknown",

volume = "30",

pages = "951--953",

journal = "Clinical \& Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "6",

}

TY - JOUR

T1 - Streptococcal lung abscesses from a dental focus following tocilizumab: a case report

AU - de Kruif, MD

AU - van Gorp, Eric

AU - Bel, EH

AU - Gerlag, DM

AU - Kunst, PW

PY - 2012

Y1 - 2012

N2 - Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.

AB - Patients suffering from dental infections and concurrently using immunosuppressive medication are at increased risk of developing systemic streptococcal infections. Tocilizumab is a novel therapeutic agent targeting interleukin-6. We describe a case of streptococcal lung abscesses from a dental focus after use of tocilizumab for treatment of Takayasu arteritis.

M3 - Article

SN - 0392-856X

VL - 30

SP - 951

EP - 953

JO - Clinical & Experimental Rheumatology

JF - Clinical & Experimental Rheumatology

IS - 6

ER -